Inactive Instrument
Optigenex Inc. Stock Other OTC
Stocks
OPGX
US6838863032
Pharmaceuticals
OTC Markets Traded| Market Cap | 19.94K 17.08K 15.98K 14.63K 27.45K 1.91M 27.81K 189K 73.62K 958K 74.85K 73.23K 3.17M | P/E 2006 * |
-
| P/E 2007 | - |
|---|---|---|---|---|---|
| Enterprise Value | 8.95M 7.67M 7.18M 6.57M 12.33M 857M 12.49M 84.79M 33.07M 430M 33.62M 32.89M 1.42B | EV / Sales 2006 |
20.5x | EV / Sales 2007 | 19.3x |
| Free-Float |
21.27% | Yield 2006 * |
-
| Yield 2007 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel A. Zwiren
CEO | Chief Executive Officer | 69 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 35 | ||
| +0.88% | +6.38% | +76.40% | +126.87% | 1,119B | ||
| +1.07% | +3.80% | +50.73% | +64.25% | 651B | ||
| +1.20% | +6.21% | +25.81% | +80.15% | 468B | ||
| +1.02% | +5.77% | +43.63% | +43.06% | 374B | ||
| +0.85% | +4.07% | +24.97% | +41.00% | 302B | ||
| +1.26% | +6.81% | +2.27% | +13.65% | 259B | ||
| +1.88% | +5.81% | +49.57% | +70.71% | 238B | ||
| +1.59% | +2.09% | -17.33% | -53.85% | 208B | ||
| +1.87% | +5.61% | +27.32% | +89.67% | 181B | ||
| Average | +1.16% | +5.17% | +31.49% | +52.83% | 422.21B | |
| Weighted average by Cap. | +1.14% | +5.40% | +44.26% | +72.42% |
| 2006 | 2007 | |
|---|---|---|
| Net sales | 301K 258K 241K 221K 414K 28.79M 420K 2.85M 1.11M 14.46M 1.13M 1.11M 47.84M | 466K 399K 373K 342K 642K 44.58M 650K 4.41M 1.72M 22.4M 1.75M 1.71M 74.08M |
| Net income | -7.36M -6.3M -5.9M -5.4M -10.13M -704M -10.26M -69.67M -27.17M -354M -27.63M -27.03M -1.17B | -2.9M -2.48M -2.32M -2.13M -3.99M -277M -4.04M -27.44M -10.7M -139M -10.88M -10.64M -461M |
| Net Debt | 6M 5.14M 4.81M 4.4M 8.26M 574M 8.37M 56.81M 22.15M 288M 22.53M 22.04M 954M | 8.93M 7.65M 7.16M 6.55M 12.3M 855M 12.46M 84.6M 32.99M 429M 33.55M 32.82M 1.42B |
Employees
-
Sector
Pharmaceuticals
















